Company profile: EmpiraMed
1.1 - Company Overview
Company description
- Provider of registry patient-engagement software to generate real-world evidence for the life science industry, delivering a decentralized clinical study solution with automated study execution, novel patient recruitment, and mobile device independence. Products include PRO, PMR, and MED Portals, Decentralized Study Platform, Patient Incentive System, and Data Verification Model.
Products and services
- Decentralized Study Platform: A device-independent platform orchestrating registries and clinical trials, combining novel patient recruitment, automated study execution via rules-engine, and integrated data capture and study automation
- PRO Portal: A rules-based PRO platform that automates patient-reported outcome studies while integrating virtual patient engagement with clinical workflows to synchronize data collection with workflows
- Data Verification Model: An analytics-driven toolkit validating patient-reported data accuracy using internal consistency checks, instrument comparisons, and external agreement measures to corroborate real-world evidence integrity
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to EmpiraMed
Datatrial
HQ: United Kingdom
Website
- Description: Provider of an integrated nowEDC system delivering data capture, verification and validation, query management, data extract, randomization, and real-time reporting. Easy to use, fully validated and highly configurable, its flexibility suits complex and adaptive trial designs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Datatrial company profile →
Cradle
HQ: The Netherlands
Website
- Description: Provider of a biotech machine-learning platform that uses prediction algorithms and AI design recommendations to assist biologists in designing proteins, offering complete IP ownership and maintaining the privacy and security of sequences and data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cradle company profile →
eLabNext
HQ: The Netherlands
Website
- Description: Provider of a digital lab platform for life science R&D with flexible lab information management software: eLabJournal (digital lab notebook for data, samples, protocols/SOPs), eLabInventory (secure sample management with inventory visualization), eLabProtocols (SOP management), a mobile app, cloud/private/on-premises hosting, and RackScan that reads racks with up to 96 barcoded vials; configurable with step-by-step implementation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full eLabNext company profile →
Abbott
HQ: United States
Website
- Description: Provider of lab data management solutions, including LIMS, SDMS, and ELN, that integrate with current systems and can be rapidly configured to fit unique workflows without adding complexity or interrupting daily operations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abbott company profile →
Synthace
HQ: United Kingdom
Website
- Description: Provider of a SaaS digital experiment platform for life science R&D that digitizes experiments end-to-end, enabling scientists to design, simulate, run, and analyze reproducible experiments without code. Integrates data and metadata, supports dynamic automation for frequent updates, offers a drag-and-drop workflow builder translating human directions to robot instructions, and DOE tools for media optimization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synthace company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for EmpiraMed
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to EmpiraMed
2.2 - Growth funds investing in similar companies to EmpiraMed
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for EmpiraMed
4.2 - Public trading comparable groups for EmpiraMed
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →